Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
Add more filters










Publication year range
1.
J Sleep Res ; 25(6): 625-635, 2016 12.
Article in English | MEDLINE | ID: mdl-27252090

ABSTRACT

An accurate home sleep study to assess electroencephalography (EEG)-based sleep stages and EEG power would be advantageous for both clinical and research purposes, such as for longitudinal studies measuring changes in sleep stages over time. The purpose of this study was to compare sleep scoring of a single-channel EEG recorded simultaneously on the forehead against attended polysomnography. Participants were recruited from both a clinical sleep centre and a longitudinal research study investigating cognitively normal ageing and Alzheimer's disease. Analysis for overall epoch-by-epoch agreement found strong and substantial agreement between the single-channel EEG compared to polysomnography (κ = 0.67). Slow wave activity in the frontal regions was also similar when comparing the single-channel EEG device to polysomnography. As expected, Stage N1 showed poor agreement (sensitivity 0.2) due to lack of occipital electrodes. Other sleep parameters, such as sleep latency and rapid eye movement (REM) onset latency, had decreased agreement. Participants with disrupted sleep consolidation, such as from obstructive sleep apnea, also had poor agreement. We suspect that disagreement in sleep parameters between the single-channel EEG and polysomnography is due partially to altered waveform morphology and/or poorer signal quality in the single-channel derivation. Our results show that single-channel EEG provides comparable results to polysomnography in assessing REM, combined Stages N2 and N3 sleep and several other parameters, including frontal slow wave activity. The data establish that single-channel EEG can be a useful research tool.


Subject(s)
Electroencephalography/methods , Polysomnography , Sleep Medicine Specialty/methods , Sleep Stages/physiology , Adult , Aged , Aged, 80 and over , Aging/physiology , Alzheimer Disease/physiopathology , Electrodes , Female , Forehead , Frontal Lobe/physiology , Frontal Lobe/physiopathology , Humans , Male , Middle Aged , Reproducibility of Results , Sleep Apnea, Obstructive/physiopathology , Sleep, REM/physiology , Time Factors
2.
Cell Metab ; 18(3): 416-30, 2013 Sep 03.
Article in English | MEDLINE | ID: mdl-24011076

ABSTRACT

The mammalian Sir2 ortholog Sirt1 plays an important role in metabolic regulation. However, the role of Sirt1 in the regulation of aging and longevity is still controversial. Here we demonstrate that brain-specific Sirt1-overexpressing (BRASTO) transgenic mice show significant life span extension in both males and females, and aged BRASTO mice exhibit phenotypes consistent with a delay in aging. These phenotypes are mediated by enhanced neural activity specifically in the dorsomedial and lateral hypothalamic nuclei (DMH and LH, respectively), through increased orexin type 2 receptor (Ox2r) expression. We identified Nk2 homeobox 1 (Nkx2-1) as a partner of Sirt1 that upregulates Ox2r transcription and colocalizes with Sirt1 in the DMH and LH. DMH/LH-specific knockdown of Sirt1, Nkx2-1, or Ox2r and DMH-specific Sirt1 overexpression further support the role of Sirt1/Nkx2-1/Ox2r-mediated signaling for longevity-associated phenotypes. Our findings indicate the importance of DMH/LH-predominant Sirt1 activity in the regulation of aging and longevity in mammals.


Subject(s)
Aging , Longevity , Nuclear Proteins/metabolism , Transcription Factors/metabolism , Animals , Body Temperature , Female , Hypothalamus/metabolism , Male , Mice , Mice, Transgenic , Mitochondria/metabolism , Mitochondria/pathology , Motor Activity , Muscle, Skeletal/metabolism , Nuclear Proteins/antagonists & inhibitors , Nuclear Proteins/genetics , Orexin Receptor Antagonists , Orexin Receptors/genetics , Orexin Receptors/metabolism , Phenotype , Promoter Regions, Genetic , RNA Interference , RNA, Small Interfering/metabolism , Signal Transduction , Sirtuin 1/antagonists & inhibitors , Sirtuin 1/genetics , Sirtuin 1/metabolism , Thyroid Nuclear Factor 1 , Transcription Factors/antagonists & inhibitors , Transcription Factors/genetics , Transcription, Genetic , Up-Regulation
3.
J Child Neurol ; 28(11): 1400-1405, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24065580

ABSTRACT

Children with neurodevelopmental disorders are at increased risk for sleep issues, which affect quality of life, cognitive function, and behavior. To determine the prevalence of sleep problems in children with the common neurodevelopmental disorder neurofibromatosis type 1, a cross-sectional study was performed on 129 affected subjects and 89 unaffected siblings, age 2 to 17 years, using the Sleep Disturbance Scale for Children questionnaire. Children with neurofibromatosis type 1 were significantly more likely to have disturbances in initiating and maintaining sleep, arousal, sleep-wake transition, and hyperhidrosis, but not problems with abnormal sleep breathing, or excessive somnolence. Although the overall sleep scores were higher in children with neurofibromatosis type 1, this was not related to a coexisting attention deficit disorder, cognitive impairment, or stimulant medication use. Collectively, these results demonstrate that children with neurofibromatosis type 1 are more likely to have sleep disturbances, and support the use of appropriate interventions for this at-risk population.

4.
Epilepsia ; 52(3): e7-11, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21371020

ABSTRACT

The ketogenic diet (KD) is an effective treatment for epilepsy, but its mechanisms of action are poorly understood. We investigated the hypothesis that the KD inhibits mammalian target of rapamycin (mTOR) pathway signaling. The expression of pS6 and pAkt, markers of mTOR pathway activation, was reduced in hippocampus and liver of rats fed KD. In the kainate model of epilepsy, KD blocked the hippocampal pS6 elevation that occurs after status epilepticus. Because mTOR signaling has been implicated in epileptogenesis, these results suggest that the KD may have anticonvulsant or antiepileptogenic actions via mTOR pathway inhibition.


Subject(s)
Epilepsy/diet therapy , Epilepsy/genetics , TOR Serine-Threonine Kinases/genetics , AMP-Activated Protein Kinase Kinases , Animals , Diet, Ketogenic , Disease Models, Animal , Epilepsy/pathology , Gene Expression/genetics , Hippocampus/pathology , Liver/pathology , Protein Kinases/genetics , Rats , Rats, Sprague-Dawley , Signal Transduction/genetics , Status Epilepticus/genetics
6.
Epilepsia ; 51(8): 1619-23, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20132289

ABSTRACT

The effect of the ketogenic diet on behavior and cognition is unclear. We addressed this issue in rats behaviorally and electrophysiologically.We fed postnatal day 21 rats a standard diet (SD), ketogenic diet (KD), or calorie-restricted diet (CR) for 2­3 weeks. CR controlled for the slower weight gain experienced by KD-fed rats. We assessed behavioral performance with a locomotor activity and a conditioned fear test. To evaluate possible parallel effects of diet on synaptic function, we examined paired-pulse modulation (PPM) and long-term potentiation (LTP) in the medial perforant path in vivo. KD-fed rats performed similarly to SD-fed rats on the behavioral tests and electrophysiologic assays. These data suggest that the KD does not alter behavioral performance or synaptic plasticity.


Subject(s)
Behavior, Animal/drug effects , Dietary Fats/pharmacology , Long-Term Potentiation/drug effects , Prefrontal Cortex/drug effects , Prefrontal Cortex/physiology , 3-Hydroxybutyric Acid/blood , Analysis of Variance , Animals , Animals, Newborn , Behavior, Animal/physiology , Conditioning, Classical/drug effects , Dietary Fats/administration & dosage , Excitatory Postsynaptic Potentials/drug effects , Fear/drug effects , In Vitro Techniques , Long-Term Potentiation/physiology , Motor Activity/drug effects , Patch-Clamp Techniques , Rats , Time Factors
7.
J Alzheimers Dis ; 19(2): 441-9, 2010.
Article in English | MEDLINE | ID: mdl-19749407

ABSTRACT

Amyloid-beta protein (Abeta) is well recognized as having a significant role in the pathogenesis of Alzheimer's disease (AD). The reason for the presence of Abeta and its physiological role in non-disease states is not clear. In these studies, low doses of Abeta enhanced memory retention in two memory tasks and enhanced acetylecholine production in the hippocampus in vivo. We then tested whether endogenous Abeta has a role in learning and memory in young, cognitively intact mice by blocking endogenous Abeta in healthy 2-month-old CD-1 mice. Blocking Abeta with antibody to Abeta or DFFVG (which blocks Abeta binding) or decreasing Abeta expression with antisense directed at the Abeta precursor, AbetaPP, all resulted in impaired learning in T-maze foot-shock avoidance. Finally, Abeta 1-42 facilitated induction and maintenance of long term potentiation in hippocampal slices, whereas antibodies to Abeta inhibited hippocampal LTP. In conclusion, these results indicate that in normal healthy young animals the presence of Abeta is important for learning and memory.


Subject(s)
Amyloid beta-Peptides/physiology , Maze Learning/physiology , Recognition, Psychology/physiology , Acetylcholine/metabolism , Amyloid beta-Peptides/antagonists & inhibitors , Amyloid beta-Peptides/immunology , Amyloid beta-Peptides/pharmacology , Analysis of Variance , Animals , Antibodies/pharmacology , Behavior, Animal/drug effects , Chromatography, High Pressure Liquid/methods , Conditioning, Classical/drug effects , Conditioning, Classical/physiology , Dose-Response Relationship, Drug , Electrochemical Techniques/methods , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , Hippocampus/drug effects , Hippocampus/physiology , In Vitro Techniques , Long-Term Potentiation/drug effects , Long-Term Potentiation/physiology , Male , Maze Learning/drug effects , Mice , Microdialysis/methods , Neuropsychological Tests , Peptide Fragments/antagonists & inhibitors , Peptide Fragments/immunology , Peptide Fragments/pharmacology , Peptides/pharmacology , Recognition, Psychology/drug effects , Time Factors
8.
Neurobiol Dis ; 33(1): 81-8, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18930825

ABSTRACT

A missense mutation in the fibroblast growth factor 14 (FGF14) gene underlies SCA27, an autosomal dominant spinocerebellar ataxia in humans. Mice with a targeted disruption of the Fgf14 locus (Fgf14(-/-)) develop ataxia resembling human SCA27. We tested the hypothesis that loss of FGF14 affects the firing properties of Purkinje neurons, which play an important role in motor control and coordination. Current clamp recordings from Purkinje neurons in cerebellar slices revealed attenuated spontaneous firing in Fgf14(-/-) neurons. Unlike in the wild type animals, more than 80% of Fgf14(-/-) Purkinje neurons were quiescent and failed to fire repetitively in response to depolarizing current injections. Immunohistochemical examination revealed reduced expression of Nav1.6 protein in Fgf14(-/-) Purkinje neurons. Together, these observations suggest that FGF14 is required for normal Nav1.6 expression in Purkinje neurons, and that the loss of FGF14 impairs spontaneous and repetitive firing in Purkinje neurons by altering the expression of Nav1.6 channels.


Subject(s)
Action Potentials , Fibroblast Growth Factors/metabolism , Purkinje Cells/physiology , Animals , Cerebellum/physiology , Excitatory Postsynaptic Potentials , Fibroblast Growth Factors/genetics , Immunohistochemistry , In Situ Hybridization , In Vitro Techniques , Mice , Mice, Inbred C57BL , Mice, Knockout , NAV1.6 Voltage-Gated Sodium Channel , Nerve Tissue Proteins/metabolism , Patch-Clamp Techniques , Sodium Channels/metabolism
9.
Epilepsia ; 49 Suppl 8: 94-6, 2008 Nov.
Article in English | MEDLINE | ID: mdl-19049600

ABSTRACT

Ketogenic diets (KDs) are effective treatments for epilepsy. The mechanisms of action are poorly understood. In some experimental seizure models, calorie restriction and hypoglycemia may augment the antiseizure effects of KDs. In addition, inhibiting glycolysis or diverting glucose from the glycolytic pathway inhibits seizures and possibly epileptogenesis, suggesting an interaction between energy regulation and the anticonvulsant actions of these interventions. Children on KDs frequently exhibit poor weight gain and have lower blood glucose levels compared to children on standard, balanced diets. Young rodents on a KD also exhibit slow weight gain, lower blood glucose and insulin levels, and elevated leptin levels. This review considers the possibility that calorie restriction, low serum glucose, and KDs share common cell signaling pathways to alter brain excitability. AMP-activated protein kinase (AMPK) is an attractive candidate signaling protein that could link energy balance to gene expression in such a way so as to reduce brain excitability.


Subject(s)
Blood Glucose/metabolism , Brain/metabolism , Caloric Restriction , Diet, Ketogenic , Epilepsy/diet therapy , AMP-Activated Protein Kinase Kinases , Animals , Child , Epilepsy/blood , Gene Expression , Humans , Protein Kinases/genetics , Protein Kinases/metabolism , Signal Transduction/physiology
10.
Neurosci Lett ; 433(2): 82-6, 2008 Mar 12.
Article in English | MEDLINE | ID: mdl-18241989

ABSTRACT

Leptin modulates multiple ion channels making its net effect on brain excitability difficult to predict. One method of determining leptin's net effect on brain excitability is to examine brain excitability during chronic leptin deficiency. We compared the susceptibility of leptin deficient ob/ob and wild type mice to pentylenetetrazol (PTZ) induced seizures using continuous video electroencephalogram (EEG) recordings. We found that ob/ob mice were more likely to die and were more susceptible to generalized clonic and clonic-tonic seizures than wild type mice at submaximal PTZ doses. These findings suggest that chronic leptin deficiency in vivo increases seizure susceptibility.


Subject(s)
Leptin/deficiency , Pentylenetetrazole , Seizures/physiopathology , Analysis of Variance , Animals , Dose-Response Relationship, Drug , Electroencephalography , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Obese , Reaction Time/drug effects , Seizures/chemically induced , Seizures/genetics , Severity of Illness Index
11.
Endocrinology ; 149(5): 2628-36, 2008 May.
Article in English | MEDLINE | ID: mdl-18276751

ABSTRACT

Obesity is associated with cognitive impairments. Long-term mechanisms for this association include consequences of hyperglycemia, dyslipidemia, or other factors comprising metabolic syndrome X. We found that hypertriglyceridemia, the main dyslipidemia of metabolic syndrome X, is in part responsible for the leptin resistance seen in obesity. Here we determined whether triglycerides have an immediate and direct effect on cognition. Obese mice showed impaired acquisition in three different cognitive paradigms: the active avoidance T-maze, the Morris water maze, and a food reward lever press. These impairments were not attributable to differences in foot shock sensitivity, swim speed, swimming distance, or voluntary milk consumption. Impaired cognition in obese mice was improved by selectively lowering triglycerides with gemfibrozil. Injection into the brain of the triglyceride triolein, but not of the free fatty acid palmitate, impaired acquisition in normal body weight mice. Triolein or milk (97% of fats are triglycerides), but not skim milk (no triglycerides), impaired maintenance of the N-methyl-d-aspartate component of the hippocampal long-term synaptic potential. Measures of oxidative stress in whole brain were reduced by gemfibrozil. We conclude that triglycerides mediate cognitive impairment as seen in obesity, possibly by impairing maintenance of the N-methyl-d-aspartate component of hippocampal long-term potentiation, and that lowering triglycerides can reverse the cognitive impairment and improve oxidative stress in the brain.


Subject(s)
Cognition Disorders/etiology , Hypertriglyceridemia/complications , Obesity/complications , Animals , Avoidance Learning/drug effects , Cognition Disorders/physiopathology , Diet, Atherogenic , Excitatory Postsynaptic Potentials/drug effects , Gemfibrozil/pharmacology , Hypertriglyceridemia/physiopathology , Hypolipidemic Agents/pharmacology , Lipid Peroxidation/drug effects , Male , Maze Learning , Memory/drug effects , Mice , Mice, Inbred Strains , Obesity/physiopathology , Swimming , Triolein/pharmacology
12.
J Clin Invest ; 118(1): 272-80, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18097472

ABSTRACT

Leptin is a hormone that reduces excitability in some hypothalamic neurons via leptin receptor activation of the JAK2 and PI3K intracellular signaling pathways. We hypothesized that leptin receptor activation in other neuronal subtypes would have anticonvulsant activity and that intranasal leptin delivery would be an effective route of administration. We tested leptin's anticonvulsant action in 2 rodent seizure models by directly injecting it into the cortex or by administering it intranasally. Focal seizures in rats were induced by neocortical injections of 4-aminopyridine, an inhibitor of voltage-gated K+ channels. These seizures were briefer and less frequent upon coinjection of 4-aminopyridine and leptin. In mice, intranasal administration of leptin produced elevated brain and serum leptin levels and delayed the onset of chemical convulsant pentylenetetrazole-induced generalized convulsive seizures. Leptin also reduced neuronal spiking in an in vitro seizure model. Leptin inhibited alpha-amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid (AMPA) receptor-mediated synaptic transmission in mouse hippocampal slices but failed to inhibit synaptic responses in slices from leptin receptor-deficient db/db mice. JAK2 and PI3K antagonists prevented leptin inhibition of AMPAergic synaptic transmission. We conclude that leptin receptor activation and JAK2/PI3K signaling may be novel targets for anticonvulsant treatments. Intranasal leptin administration may have potential as an acute abortive treatment for convulsive seizures in emergency situations.


Subject(s)
Hypothalamus/metabolism , Leptin/pharmacology , Receptors, AMPA/metabolism , Seizures/drug therapy , Synaptic Transmission/drug effects , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/metabolism , 4-Aminopyridine/toxicity , Administration, Intranasal , Animals , Convulsants/toxicity , Hypothalamus/pathology , Janus Kinase 2/antagonists & inhibitors , Janus Kinase 2/genetics , Janus Kinase 2/metabolism , Leptin/pharmacokinetics , Leptin/therapeutic use , Male , Mice , Mice, Knockout , Neurons/metabolism , Neurons/pathology , Pentylenetetrazole/toxicity , Phosphatidylinositol 3-Kinases/genetics , Phosphatidylinositol 3-Kinases/metabolism , Phosphoinositide-3 Kinase Inhibitors , Potassium Channel Blockers/toxicity , Potassium Channels, Voltage-Gated/antagonists & inhibitors , Potassium Channels, Voltage-Gated/genetics , Potassium Channels, Voltage-Gated/metabolism , Rats , Rats, Sprague-Dawley , Receptors, AMPA/genetics , Receptors, Leptin/agonists , Receptors, Leptin/genetics , Receptors, Leptin/metabolism , Seizures/chemically induced , Seizures/genetics , Seizures/metabolism , Seizures/pathology , Synaptic Transmission/genetics
13.
Neurobiol Dis ; 28(2): 184-96, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17714952

ABSTRACT

Mice with inactivation of the Tuberous sclerosis complex-1 (Tsc1) gene in glia (Tsc1 GFAP CKO mice) have deficient astrocyte glutamate transporters and develop seizures, suggesting that abnormal glutamate homeostasis contributes to neurological abnormalities in these mice. We examined the hypothesis that Tsc1 GFAP CKO mice have elevated extracellular brain glutamate levels that may cause neuronal death, abnormal glutamatergic synaptic function, and associated impairments in behavioral learning. In vivo microdialysis documented elevated glutamate levels in hippocampi of Tsc1 GFAP CKO mice and several cell death assays demonstrated neuronal death in hippocampus and neocortex. Impairment of long-term potentiation (LTP) with tetanic stimulation was observed in hippocampal slices from Tsc1 GFAP CKO mice and was reversed by low concentrations of NMDA antagonist, indicating that excessive synaptic glutamate directly inhibited LTP. Finally, Tsc1 GFAP CKO mice exhibited deficits in two hippocampal-dependent learning paradigms. These results suggest that abnormal glutamate homeostasis predisposes to excitotoxic cell death, impaired synaptic plasticity and learning deficits in Tsc1 GFAP CKO mice.


Subject(s)
Brain/metabolism , Glutamic Acid/metabolism , Learning Disabilities/metabolism , Neuronal Plasticity/genetics , Synaptic Transmission/genetics , Tuberous Sclerosis/metabolism , Animals , Astrocytes/metabolism , Brain/physiopathology , Disease Models, Animal , Excitatory Amino Acid Antagonists/pharmacology , Glial Fibrillary Acidic Protein/metabolism , Hippocampus/metabolism , Hippocampus/physiopathology , Homeostasis/genetics , Learning Disabilities/genetics , Learning Disabilities/physiopathology , Long-Term Potentiation/drug effects , Long-Term Potentiation/genetics , Mice , Mice, Knockout , Neocortex/metabolism , Neocortex/physiopathology , Nerve Degeneration/genetics , Nerve Degeneration/metabolism , Nerve Degeneration/physiopathology , Organ Culture Techniques , Tuberous Sclerosis/genetics , Tuberous Sclerosis/physiopathology , Tuberous Sclerosis Complex 1 Protein , Tumor Suppressor Proteins/genetics
14.
Mol Cell Neurosci ; 34(3): 366-77, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17208450

ABSTRACT

Humans with an autosomal dominant missense mutation in fibroblast growth factor 14 (FGF14) have impaired cognitive abilities and slowly progressive spinocerebellar ataxia. To explore the mechanisms that may account for this phenotype, we show that synaptic transmission at hippocampal Schaffer collateral-CA1 synapses and short- and long-term potentiation are impaired in Fgf14-/- mice, indicating abnormalities in synaptic plasticity. Examination of CA1 synapses in Fgf14-/- mice show a significant reduction in the number of synaptic vesicles docked at presynaptic active zones and a significant synaptic fatigue/depression during high/low-frequency stimulation. In addition, mEPSC frequency, but not amplitude, is decreased in hippocampal neurons derived from Fgf14-/- mice. Furthermore, expression of selective synaptic proteins in Fgf14-/- mice was decreased. These findings suggest a novel role for FGF14 in regulating synaptic plasticity via presynaptic mechanisms by affecting the mobilization, trafficking, or docking of synaptic vesicles to presynaptic active zones.


Subject(s)
Fibroblast Growth Factors/deficiency , Hippocampus/cytology , Neuronal Plasticity/genetics , Neurons/physiology , Synapses/physiology , Synaptic Transmission/genetics , Animals , Cells, Cultured , Dose-Response Relationship, Radiation , Electric Stimulation/methods , Embryo, Mammalian , Excitatory Postsynaptic Potentials/genetics , Excitatory Postsynaptic Potentials/radiation effects , Female , Fibroblast Growth Factors/physiology , Galactosides/metabolism , Hippocampus/physiology , In Vitro Techniques , Indoles/metabolism , Membrane Proteins/metabolism , Mice , Mice, Knockout , Microscopy, Electron, Transmission/methods , Nerve Tissue Proteins/metabolism , Neurons/ultrastructure , Patch-Clamp Techniques/methods , Pregnancy , Synapses/ultrastructure
15.
Neurobiol Dis ; 26(1): 14-26, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17236779

ABSTRACT

Spinocerebellar ataxia 27 (SCA27) is a recently described syndrome characterized by impaired cognitive abilities and a slowly progressive ataxia. SCA27 is caused by an autosomal dominant missense mutation in Fibroblast Growth Factor 14 (FGF14). Mice lacking FGF14 (Fgf14(-/-) mice) have impaired sensorimotor functions, ataxia and paroxysmal dyskinesia, a phenotype that led to the discovery of the human mutation. Here we extend the similarities between Fgf14(-/-) mice and FGF14(F145S) humans by showing that Fgf14(-/-) mice exhibit reliable acquisition (place learning) deficits in the Morris water maze. This cognitive deficit appears to be independent of sensorimotor disturbances and relatively selective since Fgf14(-/-) mice performed similarly to wild type littermates during cued water maze trials and on conditioned fear and passive avoidance tests. Impaired theta burst initiated long-term synaptic potentiation was also found in hippocampal slices from Fgf14(-/-) mice. These results suggest a role for FGF14 in certain spatial learning functions and synaptic plasticity.


Subject(s)
Fibroblast Growth Factors/physiology , Long-Term Potentiation/physiology , Maze Learning/physiology , Theta Rhythm , Acoustic Stimulation , Animals , Avoidance Learning/physiology , Conditioning, Psychological/physiology , Cues , Electroencephalography , Electrophysiology , Fear/physiology , Fear/psychology , Fibroblast Growth Factors/genetics , Galactosides , Hand Strength/physiology , Hippocampus/metabolism , Hippocampus/physiology , Immunohistochemistry , In Situ Hybridization , Indoles , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Motor Activity/physiology , Postural Balance/physiology , Reverse Transcriptase Polymerase Chain Reaction
16.
Pediatr Res ; 60(4): 413-7, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16940251

ABSTRACT

The ketogenic diet (KD) is an efficacious therapy for medically refractory childhood epilepsy that also slows weight gain. We tested the hypothesis that the KD slows weight gain via neurohormones involved in energy homeostasis. We found that juvenile rodents fed a KD had slower weight gain than those fed a standard diet (SD). Rats fed a KD had higher serum leptin levels and lower insulin levels compared with those fed an SD. We investigated the increase in leptin further because this change was the only one consistent with slower weight gain. Although rats fed the SD experienced slower weight gain when calorie restricted, they had serum leptin levels similar to those fed the SD ad libitum. Furthermore, leptin deficient (ob/ob) and leptin receptor deficient (db/db) mice did not show slower weight gain on the KD. All animals on the KD had elevated serum beta-hydroxybutyrate (betaHB) levels. Thus, ketosis is insufficient and a functioning leptin signaling system appears necessary for the KD to slow weight gain. The increase in leptin may contribute to the anticonvulsant effects of the KD.


Subject(s)
Ketones/administration & dosage , Ketosis/metabolism , Leptin/physiology , Obesity/diet therapy , Weight Gain/drug effects , Animals , Caloric Restriction , Diet , Leptin/blood , Leptin/genetics , Mice , Mice, Knockout , Mice, Obese , Rats , Rats, Sprague-Dawley , Receptors, Cell Surface/genetics , Receptors, Cell Surface/physiology , Receptors, Leptin
17.
Nat Neurosci ; 9(3): 381-8, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16491079

ABSTRACT

The gut hormone and neuropeptide ghrelin affects energy balance and growth hormone release through hypothalamic action that involves synaptic plasticity in the melanocortin system. Ghrelin binding is also present in other brain areas, including the telencephalon, where its function remains elusive. Here we report that circulating ghrelin enters the hippocampus and binds to neurons of the hippocampal formation, where it promotes dendritic spine synapse formation and generation of long-term potentiation. These ghrelin-induced synaptic changes are paralleled by enhanced spatial learning and memory. Targeted disruption of the gene that encodes ghrelin resulted in decreased numbers of spine synapses in the CA1 region and impaired performance of mice in behavioral memory testing, both of which were rapidly reversed by ghrelin administration. Our observations reveal an endogenous function of ghrelin that links metabolic control with higher brain functions and suggest novel therapeutic strategies to enhance learning and memory processes.


Subject(s)
Dendritic Spines/metabolism , Hippocampus/metabolism , Memory/physiology , Peptide Hormones/genetics , Synapses/metabolism , Animals , Cell Differentiation/drug effects , Cell Differentiation/physiology , Dendritic Spines/drug effects , Dendritic Spines/ultrastructure , Ghrelin , Hippocampus/drug effects , Hippocampus/ultrastructure , Learning/drug effects , Learning/physiology , Long-Term Potentiation/drug effects , Long-Term Potentiation/physiology , Male , Memory/drug effects , Memory Disorders/drug therapy , Memory Disorders/genetics , Memory Disorders/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Nootropic Agents/metabolism , Nootropic Agents/pharmacology , Peptide Hormones/pharmacology , Rats , Rats, Sprague-Dawley , Space Perception/drug effects , Space Perception/physiology , Synapses/drug effects , Synapses/ultrastructure , Synaptic Transmission/drug effects , Synaptic Transmission/genetics
18.
Eur J Neurosci ; 22(12): 2995-3005, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16367766

ABSTRACT

It remains poorly understood as to how newly synthesized proteins that are required to act at specific synapses are translocated into only selected subsets of potentiated dendritic spines. Here, we report that F-actin, a major component of the skeletal structure of dendritic spines, may contribute to the regulation of synaptic specificity of protein translocation. We found that the stabilization of F-actin blocked the translocation of GFP-CaMKII and inhibited the diffusion of 3-kDa dextran into spines (in 2-3 weeks cultures). Neuronal activation in hippocampal slices and cultured neurons led to an increase in the activation (decrease in the phosphorylation) of the actin depolymerization factor, cofilin, and a decrease in F-actin. Furthermore, the induction of long-term potentiation by tetanic stimulation induced local transient depolymerization of F-actin both in vivo and in hippocampal slices (8-10 weeks), and this local F-actin depolymerization was blocked by APV, a N-methyl-D-aspartate (NMDA) receptor antagonist. These results suggest that F-actin may play a role in synaptic specificity by allowing protein translocation into only potentiated spines, gated through its depolymerization, which is probably triggered by the activation of NMDA receptors.


Subject(s)
Actins/metabolism , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Dendritic Spines/metabolism , Neurons/cytology , 2-Amino-5-phosphonovalerate/pharmacology , Actin Depolymerizing Factors/metabolism , Animals , Blotting, Western/methods , Calcium-Calmodulin-Dependent Protein Kinase Type 2 , Cells, Cultured , Dendritic Spines/ultrastructure , Depsipeptides/pharmacology , Dextrans/metabolism , Disks Large Homolog 4 Protein , Dose-Response Relationship, Radiation , Electric Stimulation/methods , Embryo, Mammalian , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , Excitatory Postsynaptic Potentials/radiation effects , Fluorescent Antibody Technique/methods , Green Fluorescent Proteins/metabolism , Hippocampus/cytology , In Vitro Techniques , Intracellular Signaling Peptides and Proteins/metabolism , Long-Term Potentiation/drug effects , Long-Term Potentiation/physiology , Long-Term Potentiation/radiation effects , Membrane Proteins/metabolism , Microscopy, Immunoelectron/methods , Microtubule-Associated Proteins/metabolism , Neurons/drug effects , Neurons/physiology , Patch-Clamp Techniques/methods , Phosphorylation/drug effects , Phosphorylation/radiation effects , Potassium Chloride/pharmacology , Protein Transport/drug effects , Protein Transport/physiology , Rats , Time Factors , Transfection
19.
Neuron ; 48(6): 913-22, 2005 Dec 22.
Article in English | MEDLINE | ID: mdl-16364896

ABSTRACT

Aggregation of the amyloid-beta (Abeta) peptide in the extracellular space of the brain is central to Alzheimer's disease pathogenesis. Abeta aggregation is concentration dependent and brain region specific. Utilizing in vivo microdialysis concurrently with field potential recordings, we demonstrate that Abeta levels in the brain interstitial fluid are dynamically and directly influenced by synaptic activity on a timescale of minutes to hours. Using an acute brain slice model, we show that the rapid effects of synaptic activity on Abeta levels are primarily related to synaptic vesicle exocytosis. These results suggest that synaptic activity may modulate a neurodegenerative disease process, in this case by influencing Abeta metabolism and ultimately region-specific Abeta deposition. The findings also have important implications for treatment development.


Subject(s)
Amyloid beta-Peptides/metabolism , Brain/metabolism , Extracellular Fluid/metabolism , Presynaptic Terminals/metabolism , Synaptic Transmission/physiology , Action Potentials/drug effects , Action Potentials/physiology , Alzheimer Disease/metabolism , Alzheimer Disease/physiopathology , Animals , Exocytosis/physiology , Female , Hippocampus/drug effects , Hippocampus/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Microdialysis , Nerve Degeneration/metabolism , Nerve Degeneration/physiopathology , Organ Culture Techniques , Patch-Clamp Techniques , Perforant Pathway/physiology , Plaque, Amyloid/metabolism , Synaptic Transmission/drug effects , Synaptic Vesicles/metabolism
20.
Ann Neurol ; 58(6): 888-98, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16240365

ABSTRACT

Epilepsy is associated with significant neurological morbidity, including learning disabilities, motor deficits, and behavioral problems. Although the causes of neurological dysfunction in epilepsy are multifactorial, accumulating evidence indicates that seizures in themselves may directly cause brain injury. Although it is clear that seizures can result in neuronal death, it is likely that under some circumstances seizures can induce more subtle functional or structural alterations in neurons. We induced focal neocortical seizures with 4-aminopyridine in transgenic mice expressing green fluorescent protein in cortical neurons and sequentially imaged individual dendrites in living animals with two-photon laser-scanning microscopy to determine whether these seizures caused acute alterations in dendritic spine morphology. No dendritic alterations were observed in anesthetized animals during electrographic seizures over a 3-hour period. Similarly, in unanesthetized mice, low-stage, clinical electrographic seizures had minimal effect on dendritic spines. More severe, high-stage seizures in unanesthetized mice were associated with a moderate loss of spines and dendritic swelling, but this effect may have been contingent on a synergistic action of phototoxicity from the imaging method itself. Overall, our results suggest that most neocortical seizures have minimal acute effects on dendrites over several hours, but may predispose to dendritic injury under extreme conditions.


Subject(s)
Dendritic Spines/pathology , Dendritic Spines/physiology , Epilepsy, Generalized/pathology , Epilepsy, Generalized/physiopathology , 4-Aminopyridine , Anesthesia , Animals , Convulsants , Electroencephalography , Epilepsy, Generalized/chemically induced , Green Fluorescent Proteins/genetics , Lasers , Mice , Mice, Transgenic , Neocortex/pathology , Neocortex/physiopathology , Potassium Channel Blockers , Wakefulness
SELECTION OF CITATIONS
SEARCH DETAIL
...